Fundamentals screen · refreshed after the Nov 12, 2026 close
Net-cash companies
Companies whose cash and investments exceed all debt by at least a quarter of their market value. Net cash is cash plus short-term investments minus debt, from the latest quarterly balance sheet.
| # | Company | Price | Net cash | Mkt cap | Revenue YoY | P/E |
|---|---|---|---|---|---|---|
| 401 | HAWKHawkEye 360Technology | $14.67 | $503.4M | $1.44B | — | — |
| 402 | LSPDLightspeed CommerceUnclassified | $10.09 | $453.9M | $1.30B | — | — |
| 403 | EWTXEdgewise TherapeuticsHealthcare | $45.82 | $1.74B | $5.02B | — | 5.0× |
| 404 | IMMXImmix BiopharmaHealthcare | $8.07 | $232.1M | $669.0M | — | — |
| 405 | MOBIMobia MedicalHealthcare | $13.31 | $153.4M | $443.1M | — | — |
| 406 | HCIHCI GroupFinancials | $190.83 | $814.6M | $2.37B | +11.1% | 8.0× |
| 407 | CRTOCriteo S.ACommunication Services | $17.43 | $294.3M | $857.8M | −11.3% | — |
| 408 | ACICAmerican Coastal InsuranceFinancials | $10.34 | $167.7M | $489.0M | −4.5% | 4.9× |
| 409 | XFORX4 PharmaceuticalsHealthcare | $3.17 | $110.7M | $323.7M | +63.1% | — |
| 410 | POETPOET TechnologiesUnclassified | $5.21 | $307.6M | $901.6M | — | — |
| 411 | SHOEShoe Station GroupConsumer Discretionary | $14.20 | $131.6M | $386.0M | — | — |
| 412 | ESQEsquire Financial HoldingsFinancials | $131.69 | $541.6M | $1.60B | +18.9% | 30.4× |
| 413 | ODTXOdyssey TherapeuticsHealthcare | $20.10 | $326.0M | $966.2M | — | — |
| 414 | PEPGPepGenHealthcare | $5.04 | $117.2M | $349.1M | — | — |
| 415 | AIC3.aiTechnology | $12.07 | $651.1M | $1.94B | −25.5% | — |
| 416 | MRXMarex Group LimitedUnclassified | $71.68 | $1.73B | $5.19B | — | — |
| 417 | HIPOHippo HoldingsFinancials | $36.96 | $326.7M | $983.9M | +28.8% | 30.7× |
| 418 | AGIOAgios PharmaceuticalsHealthcare | $31.76 | $630.0M | $1.90B | +330.0% | — |
| 419 | OCULOcular TherapeutixHealthcare | $6.28 | $457.1M | $1.38B | −11.5% | — |
| 420 | GEMIGemini Space StationFinancials | $2.62 | $113.6M | $343.3M | — | — |
| 421 | QSQuantumScapeIndustrials | $3.88 | $790.6M | $2.40B | — | — |
| 422 | CWCOConsolidated Water CoUtilities | $25.29 | $132.6M | $405.0M | −2.1% | 25.1× |
| 423 | THMInternational Tower Hill MinesMaterials | $1.29 | $110.4M | $337.9M | — | — |
| 424 | PBLSParabilis MedicinesHealthcare | $27.69 | $1.11B | $3.42B | — | — |
| 425 | CLYMClimb BioHealthcare | $10.87 | $205.4M | $638.5M | — | — |
| 426 | CBIOCrescent BiopharmaHealthcare | $14.37 | $171.6M | $533.8M | — | — |
| 427 | GASSStealthGasUnclassified | $8.14 | $99.1M | $308.7M | — | — |
| 428 | ZDZiff DavisCommunication Services | $51.69 | $539.5M | $1.71B | −5.6% | 2.8× |
| 429 | HRMYHarmony Biosciences HoldingsHealthcare | $33.80 | $622.0M | $1.98B | +12.3% | 11.1× |
| 430 | MBLYMobileye GlobalTechnology | $5.64 | $1.50B | $4.79B | −2.4% | — |
| 431 | NLNLI HoldingsMaterials | $7.26 | $110.7M | $355.0M | +10.1% | — |
| 432 | ACADAcadia PharmaceuticalsHealthcare | $18.14 | $976.4M | $3.14B | +22.8% | 8.7× |
| 433 | TIPTTiptreeFinancials | $17.52 | $198.3M | $638.2M | −101.1% | — |
| 434 | CBKCommercial BancgroupFinancials | $32.81 | $139.7M | $449.8M | — | — |
| 435 | FLRFluorIndustrials | $49.52 | $1.97B | $6.35B | +8.8% | — |
| 436 | SGMTSagimet Biosciences Inc. Series AHealthcare | $10.93 | $240.1M | $775.0M | — | — |
| 437 | DSGNDesign TherapeuticsHealthcare | $10.58 | $208.6M | $677.5M | — | — |
| 438 | IPGPIPG PhotonicsTechnology | $70.86 | $926.0M | $3.01B | +14.6% | 74.6× |
| 439 | AMBQAmbiq MicroTechnology | $48.78 | $366.8M | $1.21B | — | — |
| 440 | CBRSCerebras SystemsTechnology | $97.75 | $7.00B | $23.22B | — | — |
| 441 | SSRMSSR MiningFinancials | $26.98 | $1.62B | $5.38B | +16.0% | 21.4× |
| 442 | ORICOric PharmaceuticalsHealthcare | $8.50 | $264.8M | $881.0M | — | — |
| 443 | PTCTPTC TherapeuticsHealthcare | $63.36 | $1.59B | $5.29B | +69.6% | — |
| 444 | VTEXVTEXUnclassified | $3.94 | $192.1M | $641.8M | — | — |
| 445 | HVTHaverty Furniture CompaniesConsumer Discretionary | $25.99 | $120.3M | $405.3M | +4.5% | 17.9× |
| 446 | MOVMovado GroupHealthcare | $31.95 | $211.6M | $712.9M | +4.9% | 17.2× |
| 447 | TSHATaysha Gene TherapiesHealthcare | $4.21 | $406.1M | $1.37B | −100.0% | — |
| 448 | LBRXLB PharmaceuticalsHealthcare | $42.46 | $403.8M | $1.37B | — | — |
| 449 | CXMSprinklrTechnology | $6.65 | $452.9M | $1.54B | +0.8% | 66.7× |
| 450 | SBCSBC Medical Group Holdings IncorporatedHealthcare | $5.34 | $160.4M | $549.2M | +13.4% | 11.2× |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.